Pictet Asset Management (Switzerland)’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
$45.6M Buy
+894,005
New +$45.6M 0.05% 306